Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter…
Why it was recalled
CGMP Deviations
What to do
The recall is ongoing. Follow the firm and FDA instructions.
Affected products and identifiers
Lot # NC185424, Exp Date: 2/12/2027; Lot # NC185479, Exp Date: 2/13/2027; Lot # NC193948, Exp Date: 10/23/2027. — N/A
Record details
Baxter Healthcare Corporation — US Nationwide; Puerto Rico; and Chile.